Urothelial cancer--mucosally confined disease can be aggressive

Editorial

M J Droller. J Urol. 2000 Jan.

. 2000 Jan;163(1):79-80.

No abstract available

Comment on

Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome.
Herr HW. Herr HW. J Urol. 2000 Jan;163(1):60-1; discussion 61-2. J Urol. 2000. PMID: 10604314
Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T, Bohin D, Kassardjian Z, Herve JM, Molinie V, Barre P, Lugagne PM, Botto H. Lebret T, et al. J Urol. 2000 Jan;163(1):63-7. J Urol. 2000. PMID: 10604315 Clinical Trial.
Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results.
Losa A, Hurle R, Lembo A. Losa A, et al. J Urol. 2000 Jan;163(1):68-71; discussion 71-2. J Urol. 2000. PMID: 10604316 Clinical Trial.
Multivariate analysis of the prognostic factors of primary superficial bladder cancer.
Millán-Rodríguez F, Chéchile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodríguez J. Millán-Rodríguez F, et al. J Urol. 2000 Jan;163(1):73-8. doi: 10.1016/s0022-5347(05)67975-x. J Urol. 2000. PMID: 10604317 Review.